3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid

Catalog No. :
ACEGVT713
CAS No. :
269409-73-6
Molecular Formula :
C13H17BO4
Molecular Weight :
248.09

IUPAC Name:3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid

3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100g98%$83.00Login to see priceIn stockIn stock
500g98%$328.00Login to see priceIn stockIn stock

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid
IUPAC Name3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid
MDL No.MFCD03411930
Molecular FormulaC13H17BO4
Molecular Weight248.09
SMILESC1=C(C=CC=C1B2OC(C(O2)(C)C)(C)C)C(=O)O
InChI KeyOPWAPCOSDAFWFB-UHFFFAOYSA-N
SynonymAC-2891 | AKOS015915430 | AM20050468 | DTXSID10370423 | AS-2286 | HY-W003049 | MFCD03411930 | Z1741960619 | 3-BORONOBENZOIC ACID PINACOL ESTER | BENZOIC ACID, 3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)- | T3162 | 2-(3-Carboxyphenyl)-4,4,5,5-tetrameth
CAS No.269409-73-6
PubChem CID2734653

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACEGVT713 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDHIA843 route compound structure diagram
    ACDHIA843618-51-9 In Stock
  2. Then
  3. ACEGVT713 route product structure diagram
    ACEGVT713269409-73-6 In Stock
Inquiry

2. ACEGVT713 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. ACEADR356 route compound structure diagram
    ACEADR356585-76-2 In Stock
  4. Then
  5. ACEGVT713 route product structure diagram
    ACEGVT713269409-73-6 In Stock
Inquiry

Comments (0)